Sylvant 400mg: Affected lot is labelled with the incorrect expiry date found on the vial and carton.
Brand(s)
Last updated
Summary
Product
Sylvant
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Distribution
National
Ontario
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot number |
|---|---|---|---|---|---|
Sylvant 400mg |
Sylvant 400mg |
DIN 02435136 |
Powder For Solution |
Siltuximab 400mg/Fiole |
NDI46015.C |
Issue
Affected lot is labelled with the incorrect expiry date found on the vial and carton.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Recordati Rare Diseases Canada Inc. 3080 Yonge Street Suite 6060, Toronto, ON, M4N 3N1
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Ontario
Recall class
Type III
Identification number
RA-77381
Get notified
Receive notifications for new and updated recalls and alerts by category.